Your browser doesn't support javascript.
loading
Impacts of anticancer drug parity laws on mortality rates.
Shen, Yichen; Noguchi, Haruko.
Afiliação
  • Shen Y; Graduate School of Economics, Waseda University, 1-6-1 Nishi-Waseda, Shinjuku, Tokyo, 169-8050, Japan. Electronic address: shenyc@toki.waseda.jp.
  • Noguchi H; Faculty of Political Science and Economics, Waseda University, 1-6-1 Nishi-Waseda, Shinjuku, Tokyo, 169-8050, Japan. Electronic address: h.noguchi@waseda.jp.
Soc Sci Med ; 272: 113714, 2021 03.
Article em En | MEDLINE | ID: mdl-33545495
ABSTRACT
This study investigates the impacts of anticancer drug parity laws on mortality rates in the United States using a difference-in-differences approach. Using data from 2004 to 2017 Compressed Mortality Files, we show that the anticancer drug parity laws reduce the mortality rate for head/neck malignant cancers but have no impact on malignant cancers of other types. We also rule out an insurance expansion channel that may influence the relationship between anticancer drug parity laws and malignant cancer mortality. Our results are robust to various specifications and falsification tests. Our findings imply that providing equal access to oral anticancer drugs is an effective tool for the prevention of premature mortality.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article